Q&A: Proskauer’s Rick Zall talks behavioral-health M&A and policy


Proskauer Rose, Rick Zall, law, healthcare, mental health, behavioral health, Congress, legislation, Donald Trump
  • Sponsor diligence increases around referral pipelines and payer networks
  • Risks: potential cutback in Medicaid spending, outdated regulations, sustainability
  • Employer and commercial markets present opportunity for more accessible services
Rick Zall serves as chair of Proskauer Rose’s healthcare department and a partner in the corporate healthcare division. Zall advises healthcare companies, investors and lenders on regulatory compliance matters in their transactions. How has the behavioral-health M&A market evolved over ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.

Digital Edition

BO_010818-cover

To read a digital copy of our latest magazine

click here

PE News Briefs